IL21 and B-cell non-Hodgkin lymphoma: Similarly, IL-21-overexpressing MSCs were found to sustain antitumor responses by local delivery of IL-21 in B-cell lymphoma BALB/c mice models, thus preventing the establishment of tumor nodules (Kim et al., 2015).